Institution

Serum Institute of India

World's largest vaccine manufacturer by volume, producing over 1.5 billion doses a year and reaching an estimated 65% of the world's children with at least one of its vaccines. Standalone revenue of Rs 10,900 crore in FY25. The Poonawalla family deploys surplus cash flow into Indian listed equities across pharma, financial services and consumer names, with Adar Poonawalla personally tracked as one of India's most aggressive private investors.

Biocon Limited

BIOCON3.40% stake

₹2,294 Cr

position

Ravinder Heights Limited

RVHL3.32% stake

₹9 Cr

position

Ventive Hospitality Limited

VENTIVE1.03% stake

₹136 Cr

position